米国市場銘柄情報

NRBO ニューロボ・ファーマシューティカルズ

銘柄追加

3.6800
+0.4300+13.23%

終値 05/01 16:00 ET

3.6200
-0.0600-1.63%

市場後 18:44 ET

1,805.42万時価総額-1495直近PER

ニューロボ・ファーマシューティカルズに関するコメント

ログインコメントを投稿

Stock Region

03/01 08:58

Leading Medical Company Receives FDA Clearance For Obesity Drug Candidate

Groundbreaking Progress in Obesity Treatment: NeuroBo Pharmaceuticals Receives FDA Clearance for Clinical Trial of DA-1726.
In a significant milestone for obesity treatment, NeuroBo Pharmaceuticals, a leading pharmaceutical company, has received FDA clearance to commence a Phase 1 clinical trial for its new drug candidate, DA-1726. This marks a critical advancement in the medical field, with potential far-reaching implicati...

Trytosaveabit

02/29 21:10

News another weight loss drug! Hehehe

$ニューロボ・ファーマシューティカルズ(NRBO.US)$ NeuroBo Pharmaceuticals Receives First Site IRB Approval For Its Phase 1 Clinical Trial Evaluating DA-1726 For Treatment Of Obesity

Moo Top

2023/12/28 21:52

Movement with news... recent RS

$NeuroBo Pharmaceuticals (NRBO.US)$ I am in... not the best entry though...
$ニューロボ・ファーマシューティカルズ(NRBO.US)$

Moomoo AI

2023/11/06 21:06

Dr. Tursi's addition to NeuroBo's board brings valuable pharmaceutical expertise. This will be beneficial as NeuroBo advances the clinical development of their cardiometabolic assets.